Characterization of Influenza-like Illness in Mexico
NCT01418287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5819
Last updated 2014-09-11
Summary
A study to characterize children and adults with influenza like symptoms and to determine risk factors for severe disease and death among those with H1N1.
Conditions
- Influenza-like Illness
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
Secretaria de Salud, Mexico
collaborator OTHER_GOV -
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
collaborator OTHER -
Instituto Nacional de Enfermedades Respiratorias
collaborator OTHER_GOV -
National Institute of Pediatrics, Mexico
collaborator OTHER_GOV -
Hospital General Dr. Manuel Gea González
collaborator OTHER_GOV -
Hospital Infantil de Mexico Federico Gomez
collaborator OTHER -
Hospital Central "Dr. Ignacio Morones Prieto"
collaborator OTHER -
Mexican Emerging Infectious Diseases Clinical Research Network
lead NETWORK
Principal Investigators
-
Arturo Galindo Fraga, Dr. · Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ)
-
Ana Alejandra Ortiz Hernández, Dr. · Instituto Nacional de Pediatría
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- Mexico
Study Locations
More Related Trials
-
Influenza Challenge Study in Healthy Volunteers
NCT02746211 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Respiratory Virus Hospitalization Study (FLU 003 Plus)
NCT01056185 ·Status: COMPLETED
-
Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.
NCT02255279 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Influenza A (H1N1) Surveillance Registry
NCT01046331 ·Status: COMPLETED
-
Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children
NCT01014091 ·Status: TERMINATED ·Phase: PHASE3
-
Pilot Study of Genotypic Analysis
NCT00421837 ·Status: COMPLETED
-
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
NCT00989287 ·Status: COMPLETED ·Phase: PHASE3
-
Respiratory Virus Outpatient Study (FLU 002 Plus)
NCT01056354 ·Status: COMPLETED
-
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.
NCT01262079 ·Status: COMPLETED
-
Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children
NCT00985790 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons
NCT04008823 ·Status: COMPLETED
-
Mechanisms of Severe Acute Influenza Consortium (MOSAIC)
NCT00965354 ·Status: COMPLETED
-
Optimizing the Influenza Clinical Decision Support Tool
NCT03415425 ·Status: COMPLETED ·Phase: NA
-
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075 ·Status: TERMINATED
-
Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women
NCT01577316 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects
NCT01342796 ·Status: COMPLETED ·Phase: PHASE2
-
B-cell Immunity to Influenza (SLVP017)- Year 1, 2009
NCT02133781 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
NCT05827926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)
NCT01024673 ·Status: COMPLETED
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00968526 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prophylactic Efficacy of Relenza Against Influenza A and B
NCT01156701 ·Status: COMPLETED
-
Response to Influenza Vaccination in Pediatric Oncology Patients
NCT05384288 ·Status: RECRUITING